SINGULAR GENOMICS SYSTEMS IN (OMIC) Stock Analyst Ratings
USA - NASDAQ:OMIC - US82933R3084 - Common Stock
20.01 USD
+0.05 (+0.25%)
ChartMill assigns a Buy % Consensus number of 80% to OMIC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.7. This target is -36.54% below the current price.
OMIC was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about OMIC.
In the previous month the buy percentage consensus was at a similar level.
OMIC was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-09 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-15 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-03-20 | UBS | Maintains | Neutral -> Neutral |
| 2024-01-23 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-01-22 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-08-10 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2022-11-08 | Goldman Sachs | Maintains | Neutral |
| 2022-08-17 | UBS | Downgrade | Buy -> Neutral |
| 2022-08-10 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2022-08-10 | B of A Securities | Downgrade | Buy -> Underperform |
| 2022-07-14 | Goldman Sachs | Maintains | Buy |
| 2022-05-11 | Goldman Sachs | Maintains | Buy |
| 2022-04-13 | Goldman Sachs | Maintains | Buy |
| 2022-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2021-06-21 | Cowen & Co. | Initiate | Outperform |
| 2021-06-21 | JP Morgan | Initiate | Overweight |
| 2021-06-21 | Goldman Sachs | Initiate | Buy |
| 2021-06-21 | B of A Securities | Initiate | Neutral |
SINGULAR GENOMICS SYSTEMS IN / OMIC FAQ
What do analysts expect the price target to be for SINGULAR GENOMICS SYSTEMS IN (OMIC)?
8 analysts have analysed OMIC and the average price target is 12.7 USD. This implies a price decrease of -36.54% is expected in the next year compared to the current price of 20.01.
How do analysts rate SINGULAR GENOMICS SYSTEMS IN (OMIC)?
The consensus rating for SINGULAR GENOMICS SYSTEMS IN (OMIC) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.